Arur Footwear schedules board meeting for Sep 3 to approve FY26 AGM
- Arur Footwear Limited holds board meeting on September 3, 2026
- Agenda includes approving notice for 36th Annual General Meeting
- Director's Report for FY26 ending March 31, 2026 to be approved
- Company rehabilitated from Corporate Insolvency Resolution Process

*this image is generated using AI for illustrative purposes only.
Arur Footwear Limited (formerly S R Industries Limited) will hold its Board of Directors meeting on Thursday, September 3, 2026. The company, which was rehabilitated from the Corporate Insolvency Resolution Process, aims to finalize key corporate governance matters for the upcoming financial year.
The primary objective of the meeting is to consider and approve the notice for the company's 36th Annual General Meeting (AGM). The Board will also fix the date, time, and venue for the AGM, alongside determining the closure dates for the Register of Members and Share Transfer Books.
Key Agenda Items
The Board meeting agenda includes several routine and statutory approvals:
- Appointing a scrutinizer to conduct the e-voting and poll process for the AGM.
- Approving the Director's Report along with all necessary annexures for the Financial Year ended March 31, 2026.
- Discussing other routine business matters as may arise during the session.
Corporate Details
Arur Footwear Limited operates with its corporate office in New Delhi and registered office in Mohali, Punjab. The company continues its post-insolvency operations under the name Arur Footwear Limited, having previously been known as S R Industries Limited.
The intimation was issued pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Nidhi Pathak, Company Secretary & Compliance Officer, signed the communication dated August 31, 2026.
How will the finalized AGM agenda reflect Arur Footwear's strategic priorities for post-insolvency growth in the upcoming fiscal year?
What specific operational or financial milestones does the Director's Report highlight to demonstrate the company's recovery trajectory since exiting the CIRP?
Are there any anticipated changes to the Board composition or executive leadership that might be discussed under 'other routine business matters'?





























